Question 1

Does job-based or Marketplace insurance cover Zepbound?

Accepted Answer

Usually not covered for weight loss: fewer than 1 in 5 large employers (18%) cover drugs like Zepbound for that; for sleep apnea it’s often covered.

Zepbound is approved for moderate-to-severe obstructive sleep apnea with obesity, and many plans that exclude weight loss cover it for that with . Bigger employers cover weight-loss drugs more often. Without coverage, Lilly sells it directly for less than the list price.

Cost: If covered, your plan’s brand-drug copay or coinsurance; if not, Lilly’s self-pay price ($299 to $449 a month in November 2026, with on-time refills).

Question 2

Does Original Medicare cover Zepbound?

Accepted Answer

Yes, for many people with obesity who don’t have type 2 diabetes: Medicare’s GLP-1 Bridge charges $50 a month.

Since July 1, 2026, people with Medicare drug coverage can get Zepbound (the KwikPen) for weight loss for a flat $50 a month through the temporary Medicare GLP-1 Bridge, with . You must be 18 or older and have a BMI of 35 or more, or 30 or more with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or kidney disease stage 3a or worse, or 27 or more with prediabetes, a past heart attack or stroke, or peripheral artery disease. You can’t use the Bridge if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (MASH), because your drug plan may cover GLP-1s for those, or if you already filled a GLP-1 through your drug plan in 2026; you pay your plan’s normal cost instead. Drug plans cover Zepbound for moderate-to-severe obstructive sleep apnea at their normal cost sharing.

Cost: $50 a month through the Bridge; the copay doesn’t count toward your Part D out-of-pocket cap.

Question 3

Does Medicare Advantage cover Zepbound?

Accepted Answer

Yes, for many people with obesity who don’t have type 2 diabetes: Medicare’s GLP-1 Bridge charges $50 a month.

Since July 1, 2026, people with Medicare drug coverage can get Zepbound (the KwikPen) for weight loss for a flat $50 a month through the temporary Medicare GLP-1 Bridge, with . You must be 18 or older and have a BMI of 35 or more, or 30 or more with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or kidney disease stage 3a or worse, or 27 or more with prediabetes, a past heart attack or stroke, or peripheral artery disease. You can’t use the Bridge if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (MASH), because your drug plan may cover GLP-1s for those, or if you already filled a GLP-1 through your drug plan in 2026; you pay your plan’s normal cost instead. Drug plans cover Zepbound for moderate-to-severe obstructive sleep apnea at their normal cost sharing. With , this is covered if your plan includes drug coverage (most do), under the same rules.

Cost: $50 a month through the Bridge; the copay doesn’t count toward your Part D out-of-pocket cap.

Question 4

Does Medicaid cover Zepbound?

Accepted Answer

Usually not for weight loss: only about 10 state Medicaid programs cover GLP-1 drugs for obesity; for sleep apnea it’s usually covered with prior authorization.

Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin cover GLP-1s for obesity, all with , and several states stopped in 2026. Moderate-to-severe obstructive sleep apnea isn’t a weight-loss use, so state Medicaid programs generally cover Zepbound for it with prior authorization.

Plan type	How it’s usually covered
Employer or MarketplaceUsually not covered	Usually not covered for weight loss: fewer than 1 in 5 large employers (18%) cover drugs like Zepbound for that; for sleep apnea it’s often covered. Zepbound is approved for moderate-to-severe obstructive sleep apnea with obesity, and many plans that exclude weight loss cover it for that with . Bigger employers cover weight-loss drugs more often. Without coverage, Lilly sells it directly for less than the list price. Cost: If covered, your plan’s brand-drug copay or coinsurance; if not, Lilly’s self-pay price ($299 to $449 a month in November 2026, with on-time refills).
Original MedicareCovered with conditions	Yes, for many people with obesity who don’t have type 2 diabetes: Medicare’s GLP-1 Bridge charges $50 a month. Since July 1, 2026, people with Medicare drug coverage can get Zepbound (the KwikPen) for weight loss for a flat $50 a month through the temporary Medicare GLP-1 Bridge, with . You must be 18 or older and have a BMI of 35 or more, or 30 or more with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or kidney disease stage 3a or worse, or 27 or more with prediabetes, a past heart attack or stroke, or peripheral artery disease. You can’t use the Bridge if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (MASH), because your drug plan may cover GLP-1s for those, or if you already filled a GLP-1 through your drug plan in 2026; you pay your plan’s normal cost instead. Drug plans cover Zepbound for moderate-to-severe obstructive sleep apnea at their normal cost sharing. Cost: $50 a month through the Bridge; the copay doesn’t count toward your Part D out-of-pocket cap.
Medicare AdvantageCovered with conditions	Yes, for many people with obesity who don’t have type 2 diabetes: Medicare’s GLP-1 Bridge charges $50 a month. Since July 1, 2026, people with Medicare drug coverage can get Zepbound (the KwikPen) for weight loss for a flat $50 a month through the temporary Medicare GLP-1 Bridge, with . You must be 18 or older and have a BMI of 35 or more, or 30 or more with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or kidney disease stage 3a or worse, or 27 or more with prediabetes, a past heart attack or stroke, or peripheral artery disease. You can’t use the Bridge if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (MASH), because your drug plan may cover GLP-1s for those, or if you already filled a GLP-1 through your drug plan in 2026; you pay your plan’s normal cost instead. Drug plans cover Zepbound for moderate-to-severe obstructive sleep apnea at their normal cost sharing. With , this is covered if your plan includes drug coverage (most do), under the same rules. Cost: $50 a month through the Bridge; the copay doesn’t count toward your Part D out-of-pocket cap.
MedicaidUsually not covered	Usually not for weight loss: only about 10 state Medicaid programs cover GLP-1 drugs for obesity; for sleep apnea it’s usually covered with prior authorization. Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin cover GLP-1s for obesity, all with , and several states stopped in 2026. Moderate-to-severe obstructive sleep apnea isn’t a weight-loss use, so state Medicaid programs generally cover Zepbound for it with prior authorization.

Is Zepbound covered by insurance?

What usually has to be true

Good to know

Related

Sources